Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, February 01, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bringing Customers a New Web Experience - Alfa Aesar Launches Redesigned Website
Thursday, January 29, 2015
The redesign provides a fresh new layout and offers improved intuitive navigation with a high degree of user-friendliness.

Promega PowerPlex® Fusion 6C System Launched
Thursday, January 29, 2015
The system improves mixture interpretation with difficult forensic casework samples.

Entry Level Microplate Solvent Evaporator
Tuesday, January 27, 2015
Porvair’s MiniVap™ blowdown evaporator takes just minutes to remove volatile organic solvents.

HT2800T All-in-Ones GC Autosampler from HTA
Tuesday, January 27, 2015
Smart technologies for the best user experience.

Illumina Announces First Targeted NGS Solution for Forensic Genomics
Thursday, January 22, 2015
MiSeq FGx™ forensic genomics system brings sample-to-answer sequencing to forensic laboratories.

SYGNIS Announces the Global Launch of TruePrime™ Single Cell WGA Kit
Wednesday, January 21, 2015
First product launched for single cell DNA amplification.

New 50 Microliter Electronic Pipettes
Tuesday, January 13, 2015
New models deliver optimized precision pipetting in the volume range of 2 - 50 µl.

QIAGEN Announces Regulatory Registration of a Lung Cancer Companion Diagnostic
Tuesday, January 13, 2015
therascreen EGFR RGQ Plasma PCR kit helps physicians to identify patients who could benefit from treatment with IRESSA when tumor tissue sample is not evaluable.

Illumina Expands World’s Most Comprehensive Next-Generation Sequencing Portfolio
Tuesday, January 13, 2015
New systems extend access to production-scale sequencing.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2565
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn